STRUCTURE-ACTIVITY ANALYSIS OF SYNTHETIC ALPHA-THROMBIN-RECEPTOR-ACTIVATING PEPTIDES

被引:23
|
作者
VANOBBERGHENSCHILLING, E [1 ]
RASMUSSEN, UB [1 ]
VOURETCRAVIARI, V [1 ]
LENTES, KU [1 ]
PAVIRANI, A [1 ]
POUYSSEGUR, J [1 ]
机构
[1] TRANSGENE SA,F-67082 STRASBOURG,FRANCE
关键词
D O I
10.1042/bj2920667
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alpha-Thrombin stimulates G-protein-coupled effectors leading to secretion and aggregation in human platelets, and to a mitogenic response in CCL39 hamster fibroblasts. Alpha-Thrombin receptors can be activated by synthetic peptides corresponding to the receptor sequence starting with serine-42, at the proposed cleavage site. We have previously determined that the agonist domain of receptor-activating peptides resides within the five N-terminal residues [Vouret-Craviari, Van Obberghen-Schilling, Rasmussen, Pavirani, Lecocq and Pouyssegur (1992) Mol. Biol. Cell. 3, 95-102], although the 7-residue peptide (SFFLRNP) corresponding to the hamster alpha-thrombin receptor was 10 times more potent than the 5-residue peptide for activation of human platelets. In the present study we have analysed the role of individual amino acids in receptor activation by using a series of modified hexa- or hepta-peptides derived from the human alpha-thrombin-receptor sequence. Cellular events examined here include phospholipase C activation, adenylyl cyclase inhibition and DNA synthesis stimulation in non-transformed CCL39 fibroblasts and a tumorigenic variant of that line (A71 cells). Modification of the peptide sequence had similar functional consequence for each of the assays described, indicating that either a unique receptor or pharmacologically indistinguishable receptor subtypes activate distinct G-protein signalling pathways. Furthermore, we found that: (1) the N-terminal serine can be replaced by small or intermediately sized amino acids (+/- hydroxyl groups) without loss of activity. However, its replacement by an aromatic side-chain or omission of the N-terminal amino group severely reduces activity. (2) An aromatic side-chain on the penultimate N-terminal residue appears to play a critical role since phenylalanine in this position can be substituted by tyrosine without complete loss of activity whereas an alanine in its place is not tolerated. (3) Deletion of the first, second or third N-terminal residue leads to a loss of activity, suggesting that a defined spacing of more than one structural component may be important for ligand-receptor interaction. Finally, we did not observe an antagonistic effect of the inactive peptides on phospholipase C activation or DNA synthesis induced by alpha-thrombin (1 nM) or SFLLRNP (3 muM).
引用
收藏
页码:667 / 671
页数:5
相关论文
共 50 条
  • [31] Structure-activity relationship of synthetic Toll-like receptor 4 agonists
    Stöver, AG
    Correia, JD
    Evans, JT
    Cluff, CW
    Elliott, MW
    Jeffery, EW
    Johnson, DA
    Lacy, MJ
    Baldridge, JR
    Probst, P
    Ulevitch, RJ
    Persing, DH
    Hershberg, RM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (06) : 4440 - 4449
  • [32] An Overview of Thrombin Inhibitors in the Perspective of Structure-activity Relationships
    Wang, Jiangming
    Sun, Xiaojing
    Li, Na
    Sheng, Ruilong
    Guo, Ruihua
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (25) : 2864 - 2930
  • [33] STRUCTURE-ACTIVITY STUDY OF OLIGODEOXYNUCLEOTIDES WHICH INHIBIT THROMBIN
    KRAWCZYK, SH
    BISCHOFBERGER, N
    GRIFFIN, LC
    LAW, VS
    SHEA, RG
    SWAMINATHAN, S
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 1995, 14 (3-5): : 1109 - 1116
  • [34] Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs
    Chiu, PJS
    Tetzloff, GG
    Foster, C
    Chintala, M
    Sybertz, EJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 321 (01) : 129 - 135
  • [35] Structure-activity relationships of novel hematoregulatory peptides
    Bhatnagar, PK
    Agner, EK
    Alberts, D
    Arbo, BE
    Callahan, JF
    Cuthbertson, AS
    Engelsen, SJ
    Fjerdingstad, H
    Hartmann, M
    Heerding, D
    Hiebl, J
    Huffman, WF
    Hysben, M
    King, AG
    Kremminger, P
    Kwon, C
    LoCastro, S
    Lovhaug, D
    Pelus, LM
    Petteway, S
    Takata, JS
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (19) : 3814 - 3819
  • [36] Action of thrombin-receptor-activating peptides (TRAP) on platelets and vascular endothelium
    Glusa, E
    Gräbner, D
    Paintz, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R284 - R284
  • [37] ESSENTIAL GROUPS IN SYNTHETIC AGONIST PEPTIDES FOR ACTIVATION OF THE PLATELET THROMBIN RECEPTOR
    CHAO, BH
    KALKUNTE, S
    MARAGANORE, JM
    STONE, SR
    BIOCHEMISTRY, 1992, 31 (27) : 6175 - 6178
  • [38] Review:: Structure-activity relationships in β-defensin peptides
    Taylor, Karen
    Barran, Perdita E.
    Dorin, Julia R.
    BIOPOLYMERS, 2008, 90 (01) : 1 - 7
  • [39] Structure-activity relationship study of ß-hairpin peptides
    Rathessan, Aparna Palakkurussi
    Chowdhary, Suvrat
    Kupke, Johannes
    Fulde, Marcus
    Koksch, Beate
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30
  • [40] Structure-activity relationship of rubiscolins as δ opioid peptides
    Yang, SZ
    Sonoda, S
    Chen, LP
    Yoshikawa, M
    PEPTIDES, 2003, 24 (04) : 503 - 508